MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$2,375,493
Prepaid expenses and
other assets
$71,507
Total current assets
$2,447,000
Operating lease
right-of-use assets
$64,307
Total assets
$2,511,307
Accumulated deficit
-$55,419,594
Total liabilities and
stockholders (deficit)...
$2,511,307
Total stockholders
(deficit) equity
-$1,291,912
Additional paid-in capital
$54,110,425
Common stock, 0.0001
par value...
$17,257
Total liabilities
$3,803,219
Deferred revenue
$3,000,000
Total current
liabilities
$766,330
Operating lease
obligations, less current...
$36,889
Accrued expenses and
other liabilities
$690,085
Accounts payable
$51,521
Current portion of
operating lease...
$24,724
Back
Back
Balance Sheet
source: myfinsight.com
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (INTI)